Dr Prendergast who is on the Board and has been involved with the business for a long time will be worth hearing from.
It's obvious that it's important for shareholders and the broader market to get a handle on what this means for the business and the FDA submission and why these results have differed from previous studies?
Iam not holding my breath for an update re Jack.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $4.958M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $38.68K | 4.838M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 5482204 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 242435 | 1 |
View Market Depth
| Last trade - 15.48pm 07/07/2025 (20 minute delay) ? |
| TRI (ASX) Chart |